Skip to main content

and
  1. No Access

    Article

    High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA

    Acute promyelocytic leukemia (APL) is one of the most curable myeloid malignancies because of its great sensitivity to all-trans retinoic acid (ATRA) and response to anthracycline therapy. In an attempt to simpli...

    M. Aljurf, F. Al Qurashi, F. Al Mohareb, E. Sahovic, F. Al Sharif in Medical Oncology (2010)